Ongoing pharmaceutical reforms in France: Implications for key stakeholder groups
Catherine Sermet*, Veronique Andrieu, Brian Godman, Eric Van Ganse, Alan Haycox, Jean Pierre Reynier
*Corresponding author for this work
Research output: Contribution to journal › Comment/debate
96Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Ongoing pharmaceutical reforms in France: Implications for key stakeholder groups'. Together they form a unique fingerprint.